- Home
-
Product Finder
- Arixtra®▼ (Fondaparinux sodium)
- Arzerra® (ofatumumab)
- Atriance® (nelarabine)
- Avamys®▼ (fluticasone furoate)
- Avodart® (dutasteride)
- Benlysta®▼ (Belimumab)
- Combodart™▼ (0.5 mg dutasteride / 0.4 mg tamsulosin hydrochloride)
- Duodart™▼ (0.5 mg dutasteride / 0.4 mg tamsulosin hydrochloride)
- Hycamtin®▼ (topotecan hydrochloride)
- ReQuip®LP (ropinirole hydrochloride prolonged-release tablets)
- ReQuip® PD (ropinirole hydrochloride prolonged-release tablets)
- ReQuip®XL (ropinirole hydrochloride prolonged-release tablets)
- ReQuip Depot® (ropinirole hydrochloride prolonged-release tablets)
- ReQuip Modutab™ (ropinirole hydrochloride prolonged-release tablets)
- ReQuip Prolib™ and ReQuip® prolonged-release tablets (ropinirole hydrochloride prolonged-release tablets)
- Revolade®▼ (eltrombopag)
- Seretide® (salmeterol xinafoate/fluticasone propionate)
- Trobalt™▼ (retigabine)
- Tyverb®▼ (lapatinib)
- Viani® (salmeterol xinafoate/fluticasone propionate)
- Votrient®▼ (pazopanib)
- Wellbutrin XR® (Bupropion hydrochloride modified release tablets)
- Belimumab (Benlysta®)
- Bupropion hydrochloride modified release tablets (Wellbutrin XR®)
- dutasteride (Avodart®)
- eltrombopag (Revolade®)
- Fondaparinux sodium (Arixtra®▼)
- fluticasone furoate (Avamys ™▼)
- lapatinib (Tyverb®▼)
- nelarabine (Atriance®)
- ofatumumab (Arzerra®)
- pazopanib (Votrient®▼)
- ropinirole hydrochloride prolonged-release tablets (ReQuip Modutab™, also known as ReQuip®LP, ReQuip® PD, ReQuip®XL, ReQuip Depot®, ReQuip Prolib™ and ReQuip® prolonged-release tablets)
- retigabine (Trobalt™▼)
- salmeterol xinafoate/fluticasone propionate (Seretide®, also known as Viani®)
- topotecan hydrochloride (Hycamtin®▼)
- News
- Media & Resources

